NEW YORK— This year, the Samuel Waxman Cancer Research Foundation awarded individual grants to six new researchers in addition to funding 18 collaborative grants and three ongoing individual grants. The Foundation expanded its scientific grants program to a total of more than $3.1 million.
"Scientists are moving new discoveries on how to reprogram the abnormal function of enzymes and genes into therapies to eradicate cancer stem cells," said Samuel Waxman, M.D., the Founder and Scientific Director of the SWCRF. "We hope you will be as excited as the members of Scientific Advisory Board who recommended these projects because they represent the best in cancer research."
The 2011-2012 collaborative research grant recipients are:
The 2011-2012 individual research grant recipients are:
About the Samuel Waxman Cancer Research Foundation
The Samuel Waxman Cancer Research Foundation is an international organization dedicated to curing and preventing cancer. The Foundation is a pioneer in cancer research, focusing on uncovering the causes of cancer and reprogramming cancer cells. We dedicate ourselves to delivering tailored, minimally toxic treatments to patients. Our mission is to eradicate cancer by bridging the gap between lab science and the patient.
Through our collaborative group of world-class scientists, the Institute Without Walls, investigators share information and tools to speed the pace of cancer research. Since its inception in 1976, the SWCRF has awarded more than $75 million to support the work of more than 175 researchers across the globe. For more information, visit waxmancancer.org .